Article (Scientific journals)
Phase I study of single ascending doses of befloxatone, a new reversible MAO-A inhibitor antidepressant
ANSSEAU, Marc; Caillé, P.; Derks, C. et al.
1992In European Neuropsychopharmacology, 2 (3), p. 300
Peer Reviewed verified by ORBi
 

Files


Full Text
Phase I study of single ascending doses of befloxatone, a new reversible MAO-A inhibitor antidepressant.pdf
Publisher postprint (600.12 kB)
Download

All documents in ORBi are protected by a user license.

Send to



Details



Keywords :
Antidepressant; Befloxatone; MAOI; Phase I study
Disciplines :
Treatment & clinical psychology
Author, co-author :
ANSSEAU, Marc ;  Université de Liège - ULg
Caillé, P.;  Delalande Lab., France
Derks, C.;  Delalande Lab., France
Cieren-Puiseux, I.;  Delalande Lab., France
Wauthy, J.;  Psychiatric Unit, C.H.U. du Sart Tilman, B-4000 Liège, Belgium
Ego, D.;  Delalande Lab., France
Curet, O.;  Delalande Lab., France
Thiola, A.;  Delalande Lab., France
Rovei, V.;  Delalande Lab., France
Jarreau, F. X.;  Delalande Lab., France
Language :
English
Title :
Phase I study of single ascending doses of befloxatone, a new reversible MAO-A inhibitor antidepressant
Publication date :
1992
Journal title :
European Neuropsychopharmacology
ISSN :
0924-977X
eISSN :
1873-7862
Publisher :
Elsevier, Amsterdam, Netherlands
Volume :
2
Issue :
3
Pages :
300
Peer reviewed :
Peer Reviewed verified by ORBi
Available on ORBi :
since 11 May 2021

Statistics


Number of views
40 (1 by ULiège)
Number of downloads
117 (1 by ULiège)

Scopus citations®
 
0
Scopus citations®
without self-citations
0
OpenCitations
 
0

Bibliography


Similar publications



Contact ORBi